Key takeaways:
Featured Biomarker
TSH (Thyroid-Stimulating Hormone)
TSH is a crucial biomarker for brain health that's often tested for in standard medical care. Produced by your pituitary gland, TSH regulates thyroid hormone production - and optimal thyroid function is essential for cognitive performance.
Why it matters for brain health: Imbalanced TSH levels have been linked to cognitive decline and increased Alzheimer's risk. The thyroid hormones regulated by TSH are critical for maintaining synaptic connections and neuroplasticity.
How to improve it:Focus on thyroid-supporting lifestyle habits: ensure adequate sleep (poor sleep disrupts thyroid function), manage stress through meditation or yoga, and support thyroid health with key nutrients like Vitamin D and methylated B vitamins. Regular exercise helps optimize thyroid hormone sensitivity, while avoiding excessive processed foods and environmental toxins can reduce thyroid burden as well.
BetterBrain insight: TSH dysfunction often begins years before clinical symptoms appear, making it a powerful early warning system for cognitive decline. Many people dismiss brain fog and fatigue as "normal aging" when optimal thyroid function could restore mental clarity and energy levels.
While standard medical ranges for TSH can go up to 4.5-5.0 μIU/mL, maintaining TSH in the BetterBrain recommended optimal range (under 3 μIU/mL) is essential for cognitive protection, especially during midlife transitions.
You can read more about TSH and relevant techniques to improve your levels on our BetterBrain Dashboard.
Content Corner
Why Is Alzheimer's More Common in Women?
Bottom line: Women account for two-thirds of Alzheimer's cases, and while longevity plays a role, hormonal changes during menopause and caregiving stress may also contribute significantly to this disparity.
The widespread belief that women face higher Alzheimer's rates simply because they live longer is only part of the story. Recent research suggests that the dramatic 2x difference in prevalence has deeper biological roots.
One compelling explanation centers on menopause. The sharp decline in estrogen during this transition may remove a key protective factor for the brain. Supporting this theory, one prospective study found a 41% reduction in Alzheimer's risk among women who used hormone replacement therapy.
Social factors may also play a role. Women make up the majority of Alzheimer's caregivers, experiencing chronic stress that may impact their own cognitive health over time.
Understanding these gender-specific risk factors opens the door to more personalized prevention strategies for protecting women's brain health.
You can learn more about this topic in our Grey Matters blog post on gender disparities in Alzheimer's disease and in the next section below.
The Complex Reality of Hormone Replacement Therapy
Bottom line: Dr. Rachel Rubin's conversation with Peter Attia reveals the nuanced landscape of HRT and why there's no one-size-fits-all approach to women's hormonal health.
About the episode: Dr. Rubin uses a powerful analogy to explain the difference between male and female hormonal aging: while men experience a gradual decline in their hormonal "gas tank" over time, women face what she calls a "castration event" at menopause - their gas tank suddenly goes empty at around age 52.
The perimenopause challenge: Before menopause, women experience perimenopause - a chaotic period where "the gas tank is overfull, and then it goes to empty really quickly without warning." This erratic hormonal fluctuation explains why many women feel like they don't recognize themselves during this transition.
The medical system's failure: The conversation highlights how the misinterpretation of the Women's Health Initiative study led to widespread abandonment of HRT, leaving generations of women without proper hormonal care. This has created a knowledge gap among physicians and opened the door for unregulated hormone clinics.
Multiple approaches work: The discussion acknowledges that there are many schools of thought on hormone therapy, and different solutions work for different women. Key considerations include:
- Timing matters: Starting HRT closer to menopause may offer different benefits than starting years later
- Multiple options exist: From bioidentical to synthetic hormones, systemic to local therapies
- Individual factors: Genetics, health history, and personal preferences all influence the best approach
- Local therapy benefits: Vaginal estrogen therapy is often underutilized despite being safe and effective
BetterBrain Takeaway: The goal isn't to advocate for any single approach, but to ensure women have access to knowledgeable healthcare providers who understand that hormonal health is brain health. Whether through HRT, lifestyle interventions, or other approaches, addressing the hormonal chaos of midlife is crucial for cognitive protection in many women.
"When you give women information about how their bodies work, they make great decisions for themselves." —Rachel Rubin
.webp)